U.S. Branched Stent Grafts Market Size & Outlook
U.S. branched stent grafts market, 2021-2028 (US$M)
Related Markets
U.S. branched stent grafts market highlights
- The U.S. branched stent grafts market generated a revenue of USD 125.6 million in 2021 and is expected to reach USD 214.3 million by 2028.
- The U.S. market is expected to grow at a CAGR of 7.9% from 2022 to 2028.
- In terms of segment, iliac stent was the largest revenue generating type in 2021.
- Iliac Stent is the most lucrative type segment registering the fastest growth during the forecast period.
Branched stent grafts market data book summary
| Market revenue in 2021 | USD 125.6 million |
| Market revenue in 2028 | USD 214.3 million |
| Growth rate | 7.9% (CAGR from 2021 to 2028) |
| Largest segment | Iliac stent |
| Fastest growing segment | Iliac Stent |
| Historical data | 2021 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Iliac Stent |
| Key market players worldwide | Medtronic PLC, BIOTRONIK, Merit Medical Systems Inc, Abbott Laboratories, Cook Medical, Cardinal Health Inc, Boston Scientific Corp, Terumo Corp |
Other key industry trends
- In terms of revenue, U.S. accounted for 44.7% of the global branched stent grafts market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. branched stent grafts market is projected to lead the regional market in terms of revenue in 2028.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 214.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Branched Stent Grafts Market Scope
Branched Stent Grafts Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. branched stent grafts market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branched stent grafts market will help companies and investors design strategic landscapes.
Iliac stent was the largest segment with a revenue share of 37.9% in 2021. Horizon Databook has segmented the U.S. branched stent grafts market based on iliac stent covering the revenue growth of each sub-segment from 2021 to 2028.
The U.S. accounted for largest share of 89.98% of global branched stent graft market in 2021. The increase in adaptation & adoption of newer medical techniques is driving the product need in the U.S.
According to CDC, cigarette smoking remains the leading cause of disability and diseases in the U.S. In 2019, approximately 14 in every 100 adults 18 years of age or older smoked cigarettes in the U.S. This means that more than 16 million Americans live with a smoking-related disease.
Reasons to subscribe to U.S. branched stent grafts market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. branched stent grafts market databook
-
Our clientele includes a mix of branched stent grafts market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. branched stent grafts market , including forecasts for subscribers. This country databook contains high-level insights into U.S. branched stent grafts market from 2021 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. branched stent grafts market size, by type, 2021-2028 (US$M)
U.S. Branched Stent Grafts Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
